Guidance

Breast screening: interval cancers

How to report, classify and monitor interval cancers and cancers following previous assessment.

• From: Public Health England
• Published: 8 August 2017
• Last updated: 25 February 2021 — See all updates

Applies to England

Documents

Breast screening: reporting, classification and monitoring of interval cancers and cancers following previous assessment

Ref: PHE publications gateway number GW-1444

HTML

Breast screening: interval cancer collection forms

Ref: PHE publications gateway number GW-1444

ODT, 102 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Breast screening: previous assessment review form

Ref: PHE publications gateway number GW-1444

ODT, 19.1 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Breast screening: interval cancer pathway

Ref: PHE publications gateway number GW-1444

HTML

Breast screening: screen detected pathway

Ref: PHE publications gateway number GW-1444

HTML

Details

Interval cancers are cancers that are diagnosed in between screening episodes only within the routine population and very high risk NHS breast screening programmes. The management of women screened through family history services is governed by National Institute for Health and Care Excellence (NICE) guidance.

This document provides advice for services on:

• reporting, classification and monitoring of interval cancers
• how to carry out reviews for cancers that occur following a previous assessment

See Breast screening: interval cancers and duty of candour toolkit for guidance on the role of breast screening and symptomatic services in identifying interval cancers and giving results to women.

Contact the PHE Screening helpdesk with any queries about this publication, making sure you include its full title.

Published 8 August 2017
Last updated 25 February 2021 + show all updates

1. 25 February 2021

   Added information to 'Overview' section to explain that the management of women screening through family history services is governed by NICE guidance.

2. 29 July 2020

   Guidance updated after programme review.

3. 8 August 2017

   First published.